# The role of exosomes in ankylosing spondylitis: from biological features and functional cargo to clinical applications

**Authors:** Han-ying Yuan, Jia Xu, You-yu Zhang, Xuan Xi, Heng Pan, Shu-jing Zhao, Kai-xu Li, De-hong Li, Yan Lu

PMC · DOI: 10.3389/fmolb.2026.1744396 · Frontiers in Molecular Biosciences · 2026-02-16

## TL;DR

This review explores how exosomes, tiny cell-derived particles, influence ankylosing spondylitis through immune regulation and could serve as diagnostic tools.

## Contribution

The paper highlights the novel role of exosomal RNA and protein cargo in regulating AS-related pathways and their potential as biomarkers.

## Key findings

- Exosomes contribute to immune responses and inflammation in ankylosing spondylitis.
- Exosomal miRNAs, circRNAs, and lncRNAs regulate key AS-related pathways.
- Exosomes show promise as diagnostic biomarkers for ankylosing spondylitis.

## Abstract

Exosomes are small extracellular vesicles secreted by nearly all cell types and widely distributed in body fluids. They not only mediate intercellular material transfer but also play an important role in the regulation of immune pathways. Given their diverse biological functions, studies investigating the regulatory roles of exosomes in ankylosing spondylitis (AS) are receiving increasing attention. The functions of exosomes in AS largely depend on their bioactive cargo, including microRNAs (miRNAs), circular RNAs (circRNAs), long non-coding RNAs (lncRNAs), proteins, and other molecules. In addition, exosome-induced intercellular communication and modulation of immune regulatory pathways are also critical. Recent studies have shown that exosomal crosstalk mechanisms may affect major AS-related pathways, such as immune responses, inflammatory signaling, and bone metabolism balance. This review summarizes the biological characteristics of exosomes and advances in their functional cargos in AS regulation. More animal and clinical studies are needed to explore the role of exosomes in AS. The ongoing development of sequencing technologies and biotechnology indicates that exosomes hold potential as diagnostic biomarkers for AS and provide new insights into its diagnosis and treatment.

## Linked entities

- **Diseases:** ankylosing spondylitis (MONDO:0005306)

## Full-text entities

- **Genes:** HSPA4 (heat shock protein family A (Hsp70) member 4) [NCBI Gene 3308] {aka APG-2, HEL-S-5a, HS24/P52, HSPH2, RY, hsp70}, CD9 (CD9 molecule) [NCBI Gene 928] {aka BTCC-1, DRAP-27, MIC3, MRP-1, TSPAN-29, TSPAN29}, CTSK (cathepsin K) [NCBI Gene 1513] {aka CTS02, CTSO, CTSO1, CTSO2, PKND, PYCD}, CD63 (CD63 molecule) [NCBI Gene 967] {aka AD1, HOP-26, ME491, MLA1, OMA81H, Pltgp40}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, MMP14 (matrix metallopeptidase 14) [NCBI Gene 4323] {aka MMP-14, MMP-X1, MT-MMP, MT-MMP 1, MT1-MMP, MT1MMP}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, RAB27A (RAB27A, member RAS oncogene family) [NCBI Gene 5873] {aka GS2, HsT18676, RAB27, RAM}, H19 (H19 imprinted maternally expressed transcript) [NCBI Gene 283120] {aka ASM, ASM1, BWS, D11S813E, GMRSP, LINC00008}, MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, AGFG1 (ArfGAP with FG repeats 1) [NCBI Gene 3267] {aka HRB, RAB, RIP}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, IL22 (interleukin 22) [NCBI Gene 50616] {aka IL-21, IL-22, IL-D110, IL-TIF, ILTIF, TIFIL-23}, RPS27A (ribosomal protein S27a) [NCBI Gene 6233] {aka CEP80, HEL112, S27A, UBA80, UBCEP1, UBCEP80}, TRAF2 (TNF receptor associated factor 2) [NCBI Gene 7186] {aka MGC:45012, RNF117, TRAP, TRAP3}, Per2 (period circadian clock 2) [NCBI Gene 18627] {aka mKIAA0347, mPer2}, CD81 (CD81 molecule) [NCBI Gene 975] {aka CVID6, S5.7, TAPA1, TSPAN28}, TSG101 (tumor susceptibility 101) [NCBI Gene 7251] {aka TSG10, VPS23}, MIR451A (microRNA 451a) [NCBI Gene 574411] {aka MIR451, MIRN451, hsa-mir-451, hsa-mir-451a, mir-451a}, MIR155 (microRNA 155) [NCBI Gene 406947] {aka MIRN155, miRNA155, mir-155}, Mir223 (microRNA 223) [NCBI Gene 723814] {aka Mirn223, miR-223, mmu-mir-223}, MALAT1 (metastasis associated lung adenocarcinoma transcript 1) [NCBI Gene 378938] {aka HCN, LINC00047, NCRNA00047, NEAT2, PRO2853, miPEP-52}, UBC (ubiquitin C) [NCBI Gene 7316] {aka HMG20}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, WNT7B (Wnt family member 7B) [NCBI Gene 7477], CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, LSP1P5 (LSP1 pseudogene 5) [NCBI Gene 645166], ACP5 (acid phosphatase 5, tartrate resistant) [NCBI Gene 54] {aka HPAP, TRACP5a, TRACP5b, TRAP, TRAcP, TrATPase}, UBB (ubiquitin B) [NCBI Gene 7314] {aka HEL-S-50}, VWF (von Willebrand factor) [NCBI Gene 7450] {aka F8VWF, VWD}, FOXP3 (forkhead box P3) [NCBI Gene 50943] {aka AIID, DIETER, IPEX, JM2, PIDX, XPID}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, RAB27B (RAB27B, member RAS oncogene family) [NCBI Gene 5874] {aka C25KG}, SAA1 (serum amyloid A1) [NCBI Gene 6288] {aka PIG4, SAA, TP53I4}, CD82 (CD82 molecule) [NCBI Gene 3732] {aka 4F9, C33, GR15, IA4, KAI1, R2}, IL33 (interleukin 33) [NCBI Gene 90865] {aka C9orf26, DVS27, IL1F11, NF-HEV, NFEHEV}, IRF4 (interferon regulatory factor 4) [NCBI Gene 3662] {aka IMD131, LSIRF, MUM1, NF-EM5, SHEP8}, HLA-B (major histocompatibility complex, class I, B) [NCBI Gene 3106] {aka AS, B-4901, HLAB}, GSDMD (gasdermin D) [NCBI Gene 79792] {aka DF5L, DFNA5L, FKSG10, GSDMDC1}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413] {aka COB1, YAP, YAP-1, YAP2, YAP65, YKI}, PTEN (phosphatase and tensin homolog) [NCBI Gene 5728] {aka 10q23del, BZS, CWS1, DEC, GLM2, MHAM}, FSTL1 (follistatin like 1) [NCBI Gene 11167] {aka FRP, FSL1, OCC-1, OCC1, tsc36}, TOB1 (transducer of ERBB2, 1) [NCBI Gene 10140] {aka APRO5, APRO6, PIG49, TOB, TROB, TROB1}, LYZ (lysozyme) [NCBI Gene 4069] {aka AMYLD5, LYZF1, LZM}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, TNFAIP2 (TNF alpha induced protein 2) [NCBI Gene 7127] {aka B94, EXOC3L3}, IL23A (interleukin 23 subunit alpha) [NCBI Gene 51561] {aka IL-23, IL-23A, IL23P19, P19, SGRF}, TGFB3 (transforming growth factor beta 3) [NCBI Gene 7043] {aka ARVD, ARVD1, LDS5, RNHF, TGF-beta3}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, MIR223 (microRNA 223) [NCBI Gene 407008] {aka MIRN223, miRNA223, mir-223}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, FBLN1 (fibulin 1) [NCBI Gene 2192] {aka FBLN, FIBL1}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, PDCD6IP (programmed cell death 6 interacting protein) [NCBI Gene 10015] {aka AIP1, ALIX, DRIP4, HP95, MCPH29}, TBX21 (T-box transcription factor 21) [NCBI Gene 30009] {aka IMD88, T-PET, T-bet, TBET, TBLYM}
- **Diseases:** chronic inflammation (MESH:D007249), morning stiffness (MESH:D048968), osteogenesis (MESH:D010013), AD (MESH:D000544), tumor (MESH:D009369), uveitis (MESH:D014605), AS (MESH:D013167), ectopic ossification (MESH:D009999), SLE (MESH:D008180), spinal ankylosis (MESH:D000844), psoriasis (MESH:D011565), Streptococcus pneumoniae infection (MESH:D011008), inflammatory back pain (MESH:D001416), arthritis (MESH:D001168), tumor metastasis (MESH:D009362), RA (MESH:D001172), bone destruction (MESH:D001847), tumor suppressor (OMIM:601308), osteoporosis (MESH:D010024), sterile (MESH:D007246), AxSpA (MESH:D000089183), ectopic bone formation (MESH:D000072717), inflammatory bowel disease (MESH:D015212), ulcerative colitis (MESH:D003093), Staphylococcus aureus infection (MESH:D013203), HULC (MESH:D006528), immune dysregulation (OMIM:614878)
- **Chemicals:** CX5461 (MESH:C557717), paclitaxel (MESH:D017239), phospholipid (MESH:D010743), cholesterol (MESH:D002784), phosphatidylcholine (MESH:D010713), phosphatidylserine (MESH:D010718), sophoridine (MESH:D000093842), lipids (MESH:D008055), TPL (MESH:C001899), sphingolipids (MESH:D013107)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12950741/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12950741/full.md

## References

94 references — full list in the complete paper: https://tomesphere.com/paper/PMC12950741/full.md

---
Source: https://tomesphere.com/paper/PMC12950741